Skip to main content
OpenTrials
Completed

NCT Number: NCT00438893

Effects of a Long Term Dietary Portfolio and of Sequential Removal of Food Components From the Diet

The purpose of this study is to evaluate the long term effectiveness of the dietary portfolio, consisting of viscous fibers, soy products, nuts and plant sterols, as well as the effects of removing single food components from the dietary portfolio on cholesterol reduction and other cardiovascular risk factors.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinical Nutrition & Risk Factor Modification Centre, St. Michael's Hospital Health Centre

Toronto, Ontario, M5C 2T2, Canada

About this study

We have shown in 1-month metabolic studies that a dietary portfolio, consisting of soy products, viscous fibers, almonds and plant sterols in the form of margarine, can lower cholesterol to the same extent as first generation statins (cholesterol-lowering drugs). However, the long-term effectiveness of the dietary portfolio is not known. Furthermore, it is not known to what extent each of the food components contribute to the cholesterol reductions observed. We wish to therefore evaluate the long term effects of the dietary portfolio as well as the effects of removing single food components from the dietary portfolio on cholesterol reduction and other cardiovascular risk factors. We believe the removal of single food components will result in a reduction of the cholesterol-lowering effect to a similar extent as predicted with the cholesterol reductions observed when the food component is consumed alone.

Method:

66 subjects will be recruited for a 6-month to 5 year long-term dietary portfolio study with the option for continuation (re-consenting) at the end of 6, 12 or 24 months. The active dietary components consist of viscous fibers (including oat bran), soy products (including soy milk), almonds and plant sterols (sterol-enriched margarine). Lipids, blood pressure, body weight, and routine biochemical and hematology analyses will be performed over the 5 year period, with lipids and blood pressure measured at 2 monthly intervals. 40-50 subjects on the long term dietary portfolio study, all of whom will have been on the diet for at least 1 year, will be asked to remove a specific food component from their regular dietary portfolio for a 10 week period. After the 10 week period, subjects will be asked return to the normal dietary portfolio with all food components consumed and continue on the long-term dietary portfolio.

Bloods will be taken at weeks 0, 6 and 10 of the food component removal period; and at 2-monthly intervals for 20 weeks prior to and after the 10 week period while on the long-term dietary portfolio with all food components.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adult men and postmenopausal women currently enrolled in the long-term portfolio study
  • Body mass index <32 kg/m2
  • Constant body weight over last 6 months preceding the onset of the study
  • Fasting LDL-cholesterol concentration >4.1 mmol/L at diagnosis

Exclusion criteria

  • women of child-bearing potential
  • major cardiovascular event (stroke or myocardial infarction)
  • positive molecular diagnosis of familial hypercholesterolemia
  • secondary causes of hypercholesterolemia (hypothyroidism, unless treated & on a stable dose of L-thyroxine, renal or liver disease)
  • use of cholesterol-lowering medications
  • serum triglycerides >4.5 mmol/L
  • blood pressure > 145/90 mmHg
  • diabetes and/or major disorders such as liver disease, renal failure or cancer
  • major surgery <6 months prior to randomization
  • alcohol consumption >2 drinks per day

Treatment and study plan

Dietary portfolio of cholesterol-lowering foods

Dietary Supplement

A plant based dietary portfolio providing plant sterols (1.0g/1000 kcal), soy protein (22.5g/1000 kcal, viscous fibers 10 g/1000 kcal and almonds 22.5g/1000 kcal)

Primary outcomes

  1. Total cholesterol

    Time frame: At weeks 0, 2,4, 8,12, 18, 24, 34, 44, 52; then every 2 months to a total of 5 years

  2. LDL cholesterol

    Time frame: At weeks 0, 2,4, 8,12, 18, 24, 34, 44, 52; then every 2 months to a total of 5 years

  3. C-reactive protein

    Time frame: At weeks 0, 12, 24, 34, 52; then every 6 months to a total of 5 years

  4. Blood pressure

    Time frame: At weeks 0, 2,4, 8,12, 18, 24, 34, 44, 52; then every 2 months to a total of 5 years

Secondary outcomes

  1. Body Weight

    Time frame: At weeks 0, 2,4, 8,12, 18, 24, 34, 44, 52; then every 2 months to a total of 5 years

  2. Apolipoprotein A1 and B

    Time frame: At weeks 0, 2,4, 8,12, 18, 24, 34, 44, 52; then every 2 months to a total of 5 years

  3. Lp(a)

    Time frame: At weeks 0, 24, 52; then every 6 months to a total of 5 years

  4. Routine Biochemistry and hematology measurements

    Time frame: At week 0, 12, 24 and every 6 months to 5 years

  5. Compliance to dietary portfolio components

    Time frame: At years, 1, 2, 3, 4 and 5

  6. 24 hour urinary markers and electrolytes (optional)

    Time frame: At week 0 and end of years 1, 2, 3, 4 and 5

  7. Oxidative stress markers

    Time frame: week 0 and every 6 months to 5 years

Sponsors and collaborators

Lead sponsor

University of Toronto

Other

Collaborators

  • Almond Board of California
  • Canada Research Chairs Endowment of the Federal Government of Canada
  • Loblaw Companies Limited
  • Natural Sciences and Engineering Research Council, Canada
  • Unilever R&D

Registry information

Official study title

The Long-Term Effect of Viscous Fibers, Soy Protein, and Plant Sterol Foods in Combination on Serum Cholesterol and Other Risk Factors for Cardiovascular Disease

Important dates

Study start
2003
Primary completion
2009
Study completion
2009
First posted
Feb 22, 2007
Registry last updated
Oct 15, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.